Cancer Suits and Multidistrict Litigation
There has been a recent Jnuvaimo Class Action Lawsuit filed against GlaxoSmithKline, the main manufacturer of one of the leading type-2 diabetes medications. The lawsuit is being filed on behalf of a Jnuvaimo resident who developed a rare type-2 diabetes while taking GlaxoSmithKline drugs. According to the lawsuit, the drugs caused serious health problems. Some of those problems included high blood pressure, stroke, congestive heart failure, kidney failure, pancreatitis, and damage to his liver and pancreas.
GlaxoSmithKline is one of the top pharmaceutical companies in the world. The company produces the popular type-2 diabetes drug, fluconazole, which is known to help control the body’s abnormal glucose levels. In addition, GlaxoSmithKline manufactures other well-known medicines including Penicillin, Levolor, insulin, Accutane, Celgene, and Gemfibrozil. The lawsuit states that the plaintiff developed serious health problems while taking GlaxoSmithKline drugs. Some of those problems include pancreatitis, kidney failure, congestive heart failure, high blood pressure, and damage to his pancreas, liver, and kidneys.
The United States Justice Department, or U.S. Department of Justice, is responsible for many of the settlements of class action law firm lawsuits concerning medical malpractice. In this case, there are three plaintiffs who filed the class action lawsuit. All three of the plaintiffs have developed serious symptoms related to pancreatic cancer. The following are some of the symptoms: nausea, vomiting, loss of appetite, diarrhea, constipation, extreme tiredness, lack of sexual desire, and loss of weight.
Two of the plaintiffs suffer from a similar injury, which is heart failure. One plaintiff additionally has symptoms associated with multiple sclerosis, which is a neurological disease. One of the plaintiffs developed pneumonia, and another developed internal hemorrhaging. This januvia class action lawsuit claims that the defendant’s drug product, GlaxoSmithKline, caused these similar injuries. Specifically, the complaint alleges that defendants did not provide adequate warnings about the possibility of these injuries, which resulted in thousands of consumers contracting these types of illnesses. Another claim is that the defendants failed to adequately exercise care in manufacturing the drug, as the company made an enormous profit on its sale, despite knowledge of the dangers of the drug.
Plaintiffs’ attorneys, Robert A. Katz and Helen G. Cutler, contend that this is a classic case of product liability, as they argue that the defendant did not conduct reasonable care in making their product, as this harm was readily apparent to the manufacturer. In addition, the FDA, the complaint further contends, was aware of the danger of the product, as it had conducted studies prior to its release, finding that the product was both unsafe and dangerous. This januvia class action lawsuit further claims that GlaxoSmithKline was aware of the danger of the drug, yet failed to take steps to mitigate the risk. Plaintiffs further charge that the defendants knew or should have known that their product was dangerous but did not take reasonable measures to mitigate the potential danger.
The legal system, in general, is very complicated and quite often, complex. One of the benefits of januvia class action lawsuit and multidistrict litigation is that plaintiffs need only a small amount of evidence to establish their case and bring legal action against the defendant. While it is difficult to predict the outcome of such legal actions, it is important to note that most plaintiffs have been successful. Thus, if you are suffering from cancer or other cancers, it may be time to consider filing a januvia class action lawsuit.
